Literature DB >> 22553755

Clinical significance of serum biochemistry changes in mice with targeted disruption of βB2-crystallin gene.

Fen-Fen Xiang1, Bei Cui, Qian Gao, Jian-Rong Zhang, Lin Liu, Wen-Jie Li.   

Abstract

AIM: To explore the pathogenesis, influencing factors, ways of medical intervention and evaluation indicators of cataract by observing changes in serum biochemical indices in mice with targeted disruption of βB2-crystallin.
METHODS: Nine 6-week-old male mice with targeted knockout of βB2-crystallin were used as the study group, and nine age- and sex-matched normal wild-type mice as the control group. The genetype of the modeled mice was identified by PCR technique. Tropicamide and phenylephrine eye drops were used as the cycloplegic agents to observe changes in lens opacity with a slit-lamp. The lens was then removed and blood was collected for biochemical evaluation in the serum.
RESULTS: Two genotypes were successfully identified by PCR technique. Slit-lamp observation showed that the lens cortex was opaque and GSH level in the lens cortex was remarkably decreased in mice with βB2-crystallin deficiency compared with the control group (P<0.01). Serum Na(+), Cl(-), Ca(2+), Mg(2+) and Fe(2+) levels, ALT and AST activities, and TP, ALP, Cr, TC, GLU content were decreased significantly compared with the control group (P<0.05). There was no difference in LDH, P, Cu(2+), K(+) levels between the two groups (P>0.05).
CONCLUSION: Compared with the wild-type mice, serum biochemical indices underwent significant changes in mice with targeted disruption of βB2-crystallin gene, especially with abnormal distribution of Na(+)&amp;Ca(2+), which induced the formation of cataract.

Entities:  

Keywords:  cataract; knockout; mice; serum biochemistry; βB2-crystallin

Year:  2012        PMID: 22553755      PMCID: PMC3340839          DOI: 10.3980/j.issn.2222-3959.2012.01.11

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  8 in total

Review 1.  The function of alpha-crystallin in vision.

Authors:  J Horwitz
Journal:  Semin Cell Dev Biol       Date:  2000-02       Impact factor: 7.727

2.  Calcium ATPase activity and membrane structure in clear and cataractous human lenses.

Authors:  C A Paterson; J Zeng; Z Husseini; D Borchman; N A Delamere; D Garland; J Jimenez-Asensio
Journal:  Curr Eye Res       Date:  1997-04       Impact factor: 2.424

Review 3.  Alpha-crystallin.

Authors:  Joseph Horwitz
Journal:  Exp Eye Res       Date:  2003-02       Impact factor: 3.467

4.  Evaluation of five elements in lenses and aqueous humour of experimental rabbits after induced opacity.

Authors:  Filippo Cruciani; Antonietta Moramarco; Barbara Antonelli; Roberto Mollo; Corrado Balacco-Gabrieli; Sergio Costantini; Laura Ciaralli; Rosa Giordano; Alessandra Sepe; Emanuela Damore; Mauro Valeri
Journal:  J Trace Elem Med Biol       Date:  2004       Impact factor: 3.849

5.  Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts.

Authors:  Wenjie Li; Harold I Calvin; Larry L David; Kaili Wu; Ashley L McCormack; Guan-Ping Zhu; S-C Joseph Fu
Journal:  Exp Eye Res       Date:  2002-09       Impact factor: 3.467

6.  Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion.

Authors:  K P Mitton; H A Linklater; T Dzialoszynski; S E Sanford; K Starkey; J R Trevithick
Journal:  Exp Eye Res       Date:  1999-09       Impact factor: 3.467

7.  Lens proteomics: the accumulation of crystallin modifications in the mouse lens with age.

Authors:  Yoji Ueda; Melinda K Duncan; Larry L David
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

8.  Induction of cortical cataracts in cultured mouse lenses with H-89, an inhibitor of protein kinase A.

Authors:  Harold I Calvin; Kaili Wu; Wenjie Li; Li Guo; Urmi Banerjee; S-C Joseph Fu
Journal:  Curr Eye Res       Date:  2003-11       Impact factor: 2.424

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.